Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Inks Deal to Buy Signature Genomic Laboratories

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer said today that it has bolstered its genetic testing business by agreeing to buy Spokane, Wash.-based Signature Genomic Laboratories for an undisclosed sum.

Signature, which has around 120 employees, provides diagnostic cytogenetic testing for chromosome abnormalities in people with unexplained physical and developmental disabilities. It offers microarray-based diagnostic tests for both pre-natal and post-natal identification of DNA alterations associated with genetic diseases, and it recently launched services for diagnosing patients with leukemia.

"As a global leader in genetic screening technologies and services, PerkinElmer clearly has the resources and worldwide presence to enable our combined testing services to reach more patients and families," Signature Genomic Laboratories Co-founder Lisa Shaffer said in a statement.

PerkinElmer CEO Robert Friel said that the new addition will bring with it "very strong complementary assets for diagnosing disorders that are often undetected by traditional genetic tests."

PerkinElmer said it expects the deal for Signature to close sometime in May, after the regulatory waiting period under the Hart-Scott Rodino Antitrust Improvements Act expires.

Financial terms of the agreement were not released.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.